Prospective evaluation of low-dose ketoconazole plus hydrocortisone in docetaxel pre-treated castration-resistant prostate cancer patients. [electronic resource]
Producer: 20160421Description: 144-8 p. digitalISSN:- 1476-5608
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Disease Progression
- Disease-Free Survival
- Docetaxel
- Humans
- Hydrocortisone -- administration & dosage
- Ketoconazole -- administration & dosage
- Male
- Middle Aged
- Prostate-Specific Antigen -- blood
- Prostatic Neoplasms, Castration-Resistant -- blood
- Taxoids -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.